D-0445-2023 Class II Terminated
FDA drug recall D-0445-2023 was initiated by Denver Solutions, LLC DBA Leiters Health on Feb 21, 2023 and is designated Class II. Reason for recall: CGMP DEVIATIONS The recall status is terminated (terminated Jan 11, 2024). Affected quantity: 8,136 units.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 15, 2023
- Initiation Date
- Feb 21, 2023
- Termination Date
- Jan 11, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8,136 units
Product description
Phenylephrine HCl 20 mg (80 mcg/mL) added to 0.9% Sodium Chloride 250 mL IV Bag, Rx only, Leiters Compounding Health 13796 Compark Blvd Englewood CO 80112, NDC 71449-148-94
Reason for recall
CGMP DEVIATIONS
Distribution pattern
Nationwide within the United States including VA or other Government facilities
Code information
Lot #: 2231026, Exp. Date 2/23/2023; 2231051, Exp. Date 3/11/2023; 2231156, Exp. Date 5/29/2023; 2231163, Exp. Date 3/26/2023; 223130, Exp. Date 4 5/7/2023; 2231308, Exp. Date 5/11/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0445-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026